Skip to main content
. 2009 Oct 13;4(10):e7443. doi: 10.1371/journal.pone.0007443

Figure 6. GSK3β inhibition reduced stem cell characteristics in an “ex vivo” GBM cell line.

Figure 6

(A) CD133 sorting of the BS287 “ex vivo” GBM cell line. (B) Growth characteristics of the CD133+ and CD133- populations in BS287. (C) Western blot analysis of Nestin, Sox2, Bmi1 and β-actin in BS287. The CD133- population showed stem cancer-like characteristics. (D) Cells in the CD133+ population with a more differentiated geno/phenotype increased after GSK3β inhibition. (E, F) Inhibition of GSK3β led to a reduction in the number and volume of neurospheres in the BS287 “ex vivo” cell line.